Advertisement
Original Contribution
JAMA. 2006;295(10):1135-1141. doi: 10.1001/jama.295.10.1135

Coffee, CYP1A2 Genotype, and Risk of Myocardial Infarction

  1. Marilyn C. Cornelis, BSc;
  2. Ahmed El-Sohemy, PhD;
  3. Edmond K. Kabagambe, PhD;
  4. Hannia Campos, PhD
  1. Author Affiliations: Department of Nutritional Sciences, University of Toronto, Toronto, Ontario (Ms Cornelis and Dr El-Sohemy); Department of Nutrition, Harvard School of Public Health, Boston, Mass (Drs Kabagambe and Campos); and Centro Centroamericano de Poblacion, Universidad de Costa Rica, San Pedro de Montes de Oca, Costa Rica (Dr Campos).
  1. Corresponding Author: Ahmed El-Sohemy, PhD, Department of Nutritional Sciences, University of Toronto, 150 College St, Toronto, Ontario, Canada M5S 3E2 (a.el.sohemy{at}utoronto.ca).

Abstract

Context  The association between coffee intake and risk of myocardial infarction (MI) remains controversial. Coffee is a major source of caffeine, which is metabolized by the polymorphic cytochrome P450 1A2 (CYP1A2) enzyme. Individuals who are homozygous for the CYP1A2*1A allele are “rapid” caffeine metabolizers, whereas carriers of the variant CYP1A2*1F are “slow” caffeine metabolizers.

Objective  To determine whether CYP1A2 genotype modifies the association between coffee consumption and risk of acute nonfatal MI.

Design, Setting, and Participants  Cases (n = 2014) with a first acute nonfatal MI and population-based controls (n = 2014) living in Costa Rica between 1994 and 2004, matched for age, sex, and area of residence, were genotyped by restriction fragment–length polymorphism polymerase chain reaction. A food frequency questionnaire was used to assess the intake of caffeinated coffee.

Main Outcome Measure  Relative risk of nonfatal MI associated with coffee intake, calculated using unconditional logistic regression.

Results  Fifty-five percent of cases (n = 1114) and 54% of controls (n = 1082) were carriers of the slow *1F allele. For carriers of the slow *1F allele, the multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of nonfatal MI associated with consuming less than 1, 1, 2 to 3, and 4 or more cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34), respectively. Corresponding ORs (95% CIs) for individuals with the rapid *1A/*1A genotype were 1.00, 0.75 (0.51-1.12), 0.78 (0.56-1.09), and 0.99 (0.66-1.48) (P = .04 for gene × coffee interaction). For individuals younger than the median age of 59 years, the ORs (95% CIs) associated with consuming less than 1, 1, 2 to 3, or 4 or more cups of coffee per day were 1.00, 1.24 (0.71-2.18), 1.67 (1.08-2.60), and 2.33 (1.39-3.89), respectively, among carriers of the *1F allele. The corresponding ORs (95% CIs) for those with the *1A/*1A genotype were 1.00, 0.48 (0.26-0.87), 0.57 (0.35-0.95), and 0.83 (0.46-1.51).

Conclusion  Intake of coffee was associated with an increased risk of nonfatal MI only among individuals with slow caffeine metabolism, suggesting that caffeine plays a role in this association.

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals